Mark Fishman
Jump to navigation
Jump to search
Mark Fishman (researcher, businessman) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Born | 1947 | |||||||||||||
Nationality | US | |||||||||||||
Alma mater | Yale College, Harvard Medical School | |||||||||||||
Interests | Medicine | |||||||||||||
Biotech researcher for Novartis who attended the 2013 Bilderberg.
|
Mark Fishman is an American cardiologist. A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR),[1] the main research arm of Novartis Pharmaceuticals.[2]
Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[3] He is the author of over 100 publications[4] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[5][6][7]
Events Participated in
Event | Start | End | Location(s) | Description |
---|---|---|---|---|
Bilderberg/2013 | 6 June 2013 | 9 June 2013 | Watford UK | The 2013 Bilderberg group meeting. |
WEF/Annual Meeting/2014 | 22 January 2014 | 25 January 2014 | World Economic Forum Switzerland | 2604 guests in Davos considered "Reshaping The World" |
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
References
- ↑ https://web.archive.org/web/20150601033038/http://www.novartis.com/about-novartis/people/executive-committee.shtml
- ↑ https://web.archive.org/web/20110202150643/http://www.novartis.com/newsroom/fact-sheet.shtml
- ↑ https://web.archive.org/web/20110616200321/http://www.prdomain.com/companies/N/Novartis/newsreleases/20025718532.htm
- ↑ http://www.pubmed.gov 183 results as of 20 Oct 2009
- ↑ https://semanticscholar.org/paper/c906a31f1b1974e1740f26cd2939b5457fb7e162
- ↑ Forbes.com
- ↑ https://web.archive.org/web/20110725033719/http://www.baderc.org/bios/FishmanBios.pdf